Back to search

Netherlands· NL-62f3a7b8bca6

Zopranol HCTZ 30 mg/12,5 mg filmomhulde tabletten

A zofenopril und diuretika product containing hydrochloorthiazide + zofenopril calcium, registered in Netherlands by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 5 of our 19 countries.

ATC C09BA15

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedZopranol HCTZ 30 mg/12,5 mg filmomhul…ATCC09BA15REGISTER NO.NL-62f3a7b8bca6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Zofenopril und diuretika is registered in 5 of 19 countries.

Countries holding a registration under ATC C09BA15 (zofenopril und diuretika), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Zofenopril und diuretika · ATC C09BA15

5 / 19 countries

  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROCHLOORTHIAZIDE + ZOFENOPRIL CALCIUM
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Netherlands (NL)
ATC code
C09BA15
ATC class
Zofenopril und Diuretika
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    30936

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for zofenopril und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zofenopril und diuretika · interactions on record

40 records

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdb6d722-f9a6-49ef-8674-8d5f0754b17f
GET /v1/drugs/cdb6d722-f9a6-49ef-8674-8d5f0754b17f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h30936_smpc.pdf",
  "strength": null,
  "atc_label": "Zofenopril And Diuretics",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg30936",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "HYDROCHLOORTHIAZIDE",
    "ZOFENOPRIL CALCIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h30936.pdf",
  "authorised_at": "2005/04/07",
  "procedure_number": "NL/H/4680/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "30936",
  "additional_monitoring": "N"
}

See everything about zofenopril und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.